Abstract
Circumventing existing patents may be a shortcut to getting your recombinant protein to market.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Zhang, Y. et al. 1998. Protein Expr. Purif. 12: 159–165.
LaVallie, E.R. et al. 1993. Bio/Technology 11: 189–193.
Olson, P. et al. 1998. Protein Expr. Purif. 14: 160–166.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mascarenhas, D. Negotiating the maze of biotech "tool patents". Nat Biotechnol 16, 1371–1372 (1998). https://doi.org/10.1038/4357
Issue date:
DOI: https://doi.org/10.1038/4357